SCHEMBL25925772

SCHEMBL25925772

Cn1nccc1/N=N/c1c(O)ccc(/N=N/c2snc3ccc(S(N)(=O)=O)cc23)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HIF1A Q16665 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CASP6 P55212 1/20 0.35
ATM Q13315 1/20 0.35
KLF5 Q13887 1/20 0.35
GLO1 Q04760 4/20 0.34
CDK1 P06493 2/20 0.32
CCNA2 P20248 2/20 0.32
CDK2 P24941 2/20 0.32
CA1 P00915 4/20 0.32
CA2 P00918 4/20 0.32
CA12 O43570 3/20 0.32
CA9 Q16790 3/20 0.32
MAPT P10636 1/20 0.31
PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925819 0.83 MEN1 (0.42) CYP1A2CYP2C9HIF1AMEN1KMT2A
SCHEMBL25925994 0.82
SCHEMBL25925809 0.81 KMT2A (0.35) CYP1A2CYP2C9HIF1AMEN1KMT2A
SCHEMBL25925718 0.81 MEN1 (0.50) CYP1A2CYP2C9HIF1AMEN1KMT2A
SCHEMBL25925715 0.81 MEN1 (0.50) CYP1A2CYP2C9HIF1AMEN1KMT2A
SCHEMBL25925792 0.80 MEN1 (0.33) CYP1A2CYP2C9HIF1AMEN1KMT2A
SCHEMBL25927208 0.79 PTGS2 (0.36) CYP1A2CYP2C9HIF1AMEN1KMT2A
SCHEMBL25925777 0.78
SCHEMBL25925704 0.76 MAPT (0.33) MEN1KMT2ARAB9AATMGLO1
SCHEMBL25925787 0.76 BRD4 (0.37) CYP1A2CYP2C9HIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 CYP1A2 762/4885CYP2C9 1684/4885HIF1A 2876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.